Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis

BACKGROUND: The prognosis of patients with combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma (CHC) is usually poor, and effective adjuvant therapy is missing making it important to investigate whether these patients may benefit from adjuvant transarterial chemoembolization (TACE)...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:BMC Cancer
Główni autorzy: Liu, Wei-Ren, Tian, Meng-Xin, Tao, Chen-Yang, Tang, Zheng, Zhou, Yu-Fu, Song, Shu-Shu, Jiang, Xi-Fei, Wang, Han, Zhou, Pei-Yun, Qu, Wei-Feng, Fang, Yuan, Ding, Zhen-Bin, Zhou, Jian, Fan, Jia, Shi, Ying-Hong
Format: Artigo
Język:Inglês
Wydane: BioMed Central 2020
Hasła przedmiotowe:
Research Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7350756/
https://ncbi.nlm.nih.gov/pubmed/32650743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07138-z
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy